Merck Neuroscience Acquisition Brings a Startup With Parkinson’s, ALS Programs

A VPN is an essential component of IT security, whether you’re just starting a business or are already up and running. Most business interactions and transactions happen online and VPN

Merck’s acquisition of Caraway Therapeutics adds programs for genetically defined neurodegenerative diseases. One of those programs addresses a target that was the focus of a different startup purchased by Merck in 2019.

Leave a Replay

Sign up for our Newsletter

Contact Us